LINE-1 as a therapeutic target for castration-resistant prostate cancer. [electronic resource]
- Frontiers in bioscience (Landmark edition) 01 2018
- 1292-1309 p. digital
Publication Type: Journal Article; Review
2768-6698
10.2741/4644 doi
Alkynes Benzoxazines--therapeutic use Clinical Trials, Phase II as Topic Cyclopropanes Gene Expression Regulation, Neoplastic--drug effects Humans Long Interspersed Nucleotide Elements--genetics Male Prostatic Neoplasms, Castration-Resistant--drug therapy Reverse Transcriptase Inhibitors--therapeutic use Treatment Outcome